Northwell Holdings and Aegis Ventures company Caire, a platform for creating virtual care, has hired former Mayo Clinic President and CEO Emeritus Dr. John Noseworthy, appointed Executive Chairman.
Noseworthy will join the company’s Board of Directors and lead the Caire Collaborative, a consortium of healthcare systems acting as investors, partners and early adopters of Caire’s in-person and virtual care model.
“The pandemic has opened the door to a hybrid healthcare model,” Noseworthy said in a statement. “I want health systems to be at the center of this progress, identifying the most critical health problems that can be addressed through innovation, artificial intelligence and digital tools. We can and should take advantage of new technologies to bridge the gaps and disparities in care.” We couldn’t do that before. I look forward to using my knowledge and industry experience to help shape the future of healthcare.
Loyal, a digital healthcare platform designed to help healthcare systems and hospitals connect with patients, announced that Matt Gove has joined its team as Senior Advisor.
Gove previously held the position of chief marketing officer for the New York-based company Summit Health, a multidisciplinary medical practice and parent company of emergency care provider CityMD. Walgreens-backed VillageMD bought Summit Health in November.
He was also the chief consumer officer for the Georgia-based healthcare system Piedmont Healthcare.
Gove will work directly with Loyal’s CEO, Chad Mallory, providing strategic advice as the company looks to expand its platform.
“It’s been exciting to see healthcare companies finally welcoming their customers and offering digital tools that meet patients where they are. The next step for these companies is to find a solution that not only makes it easier for patients, but also provides a consolidated platform that actually improves operations as well,” Gove said in a statement. “Loyal is the only platform that can do that and I’m incredibly excited to be a part of this at this point in its growth.”
AI-powered pathology company PathAI announced that Matt Grow is joining its team as President of Biopharma and Chief Business Officer.
Grow will work to expand PathAI’s commercial biopharma organization with a focus on the company’s algorithm product suite and clinical trial service offerings for biopharma partners.
Previously, he was senior vice president and global head of biopharma business development at pharmaceutical contract research organization PPD and Thermo Fisher Scientific.
“I have supported biopharmaceuticals in this industry for over twenty years and am excited by PathAI’s end-to-end portfolio and how the technology is driving drug development. I’m delighted to be part of such a strong team,” Grow said in a statement. “As the portfolio evolves, PathAI strengthens its position to meet the precise needs of each client across the spectrum of drug development. My goal is to make sure we do this in the most effective way possible.”
